CEMI - Chembio Diagnostics gets $4M HIV test purchase order

Chembio Diagnostics (CEMI) has received a $4M purchase order from the Partnership for Supply Chain Management ((PFSCM)) for the purchase of the company's HIV 1/2 STAT-PAK Assay for shipment to Ethiopia into early 2022.The HIV 1/2 STAT-PAK Assay is a World Health Organization ((WHO)) prequalified, rapid point-of-care assay for the detection of HIV-1 and HIV-2 antibodies in fingerstick whole blood, venous whole blood, serum, or plasma.A version of the assay for the U.S. market has received premarket approval ((PMA)) and a Clinical Laboratory Improvement Amendments ((CLIA)) waiver from the U.S. FDA.However, the delivery of the full number of tests covered by the purchase order may be affected by limitations of Chembio’s supply chain, staffing, and liquidity, the company said.

For further details see:

Chembio Diagnostics gets $4M HIV test purchase order